Kelley DS, Daudu PA, Taylor PC, Mackey BE, Turnlund JR
P., Zhu, X., Perry, G., & Smith, M
Though its yet to hit the mainstream, its been a hit with so-called grey market pharmacies that sell unapproved drugs under the guise that they re only for research purposes. Such pharmacies can be a vital pipeline of hormones and other compounds for trans and non-binary people seeking gender-affirming care, providing affordable alternatives to what youd get through your health insurance, but theyre also an outlet of drugs with questions about their efficacy and safety, like anabolic steroids and human growth hormone
Here are concrete cost projections for common scenarios
What remains speculative or early-stage: Specific peptide stacking protocols for neuropathy have not been tested in controlled clinical trials